[go: up one dir, main page]

About: Sacrosidase

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID.

Property Value
dbo:abstract
  • Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID. (en)
dbo:alternativeName
  • Sucraid (en)
dbo:casNumber
  • 85897-35-4
dbo:chEMBL
  • 1201487
dbo:fdaUniiCode
  • 8A7F670F2Y
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 5120174 (xsd:integer)
dbo:wikiPageLength
  • 2579 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1102370991 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • A16 (en)
dbp:atcSuffix
  • AB06 (en)
dbp:casNumber
  • 85897 (xsd:integer)
dbp:chembl
  • 1201487 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:legalUs
  • Rx-only (en)
dbp:routesOfAdministration
  • Oral (en)
dbp:tradename
  • Sucraid (en)
dbp:unii
  • 8 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 464385984 (xsd:integer)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sacrosidase assists in the breakdown of sugar/sucrose into simpler forms and is useful for the relief of gastrointestinal symptoms that are associated with CSID. (en)
rdfs:label
  • Sacrosidase (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License